Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection

By Destin Groff, Ashley Sun, A. Ssentongo, D. Ba, N. Parsons, G. Poudel, A. Lekoubou, John S. Oh, J. Ericson, P. Ssentongo and 1 more. JAMA Network Open, 2021

702 citations recorded by the source corpus.

Key Points Question What are the short-term and long-term postacute sequelae of COVID-19 (PASC) infection? Findings In this systematic review of 57 studies comprising more than 250 000 survivors of COVID-19, most sequelae included mental health, pulmonary, and neurologic disorders, which were prevalent longer than 6 months after SARS-CoV-2 exposure. Meaning These findings suggest that long-term PASC must be factored into existing health care systems, especially in low- and middle-income countries.

Subfields: Infectious Diseases, Molecular Biology, Neurology

View Paper: https://www.semanticscholar.org/paper/9965dec65dc778bd650f44f5555badc36784177b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Kamlesh Khunti
A. Routen
L. O’Mahoney
J. Sterne
Anneka E. Welford
U. Karamchandani
T.L. Ward
A. Banerjee

Citations in the corpus

The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis (2022, positive): “…either focused largely on hospitalised populations, 5,7 are limited to studies with follow-up to ∼ eight months, are published prior to March 2021 5,7 , and have included specialist study populations such as patients treated in a specialist respiratory clinic which may bias general population…”